BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22952938)

  • 1. SHP-1 phosphatase is a critical regulator in preventing natural killer cell self-killing.
    Mahmood S; Kanwar N; Tran J; Zhang ML; Kung SK
    PLoS One; 2012; 7(8):e44244. PubMed ID: 22952938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1.
    Lowin-Kropf B; Kunz B; Beermann F; Held W
    J Immunol; 2000 Aug; 165(3):1314-21. PubMed ID: 10903732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dephosphorylation of the adaptor LAT and phospholipase C-γ by SHP-1 inhibits natural killer cell cytotoxicity.
    Matalon O; Fried S; Ben-Shmuel A; Pauker MH; Joseph N; Keizer D; Piterburg M; Barda-Saad M
    Sci Signal; 2016 May; 9(429):ra54. PubMed ID: 27221712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
    Yusa S; Campbell KS
    J Immunol; 2003 May; 170(9):4539-47. PubMed ID: 12707331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2004 Jun; 172(12):7385-92. PubMed ID: 15187115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
    Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
    J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases.
    Le Dréan E; Vély F; Olcese L; Cambiaggi A; Guia S; Krystal G; Gervois N; Moretta A; Jotereau F; Vivier E
    Eur J Immunol; 1998 Jan; 28(1):264-76. PubMed ID: 9485206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHP-2 expression negatively regulates NK cell function.
    Purdy AK; Campbell KS
    J Immunol; 2009 Dec; 183(11):7234-43. PubMed ID: 19915046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand binding to inhibitory killer cell Ig-like receptors induce colocalization with Src homology domain 2-containing protein tyrosine phosphatase 1 and interruption of ongoing activation signals.
    Vyas YM; Maniar H; Lyddane CE; Sadelain M; Dupont B
    J Immunol; 2004 Aug; 173(3):1571-8. PubMed ID: 15265884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHP-1-mediated inhibitory signals promote responsiveness and anti-tumour functions of natural killer cells.
    Viant C; Fenis A; Chicanne G; Payrastre B; Ugolini S; Vivier E
    Nat Commun; 2014 Oct; 5():5108. PubMed ID: 25355530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of SHP-1 activity by PKC-θ regulates NK cell activation threshold and cytotoxicity.
    Ben-Shmuel A; Sabag B; Puthenveetil A; Biber G; Levy M; Jubany T; Awwad F; Roy RK; Joseph N; Matalon O; Kivelevitz J; Barda-Saad M
    Elife; 2022 Mar; 11():. PubMed ID: 35258455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells.
    Carrega P; Pezzino G; Queirolo P; Bonaccorsi I; Falco M; Vita G; Pende D; Misefari A; Moretta A; Mingari MC; Moretta L; Ferlazzo G
    PLoS One; 2009 Dec; 4(12):e8132. PubMed ID: 19997637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia Impairs NK Cell Cytotoxicity through SHP-1-Mediated Attenuation of STAT3 and ERK Signaling Pathways.
    Teng R; Wang Y; Lv N; Zhang D; Williamson RA; Lei L; Chen P; Lei L; Wang B; Fu J; Liu X; He A; O'Dwyer M; Hu J
    J Immunol Res; 2020; 2020():4598476. PubMed ID: 33123602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cell receptors.
    Lanier LL
    Annu Rev Immunol; 1998; 16():359-93. PubMed ID: 9597134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase.
    Nakamura MC; Niemi EC; Fisher MJ; Shultz LD; Seaman WE; Ryan JC
    J Exp Med; 1997 Feb; 185(4):673-84. PubMed ID: 9034146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors.
    Burshtyn DN; Lam AS; Weston M; Gupta N; Warmerdam PA; Long EO
    J Immunol; 1999 Jan; 162(2):897-902. PubMed ID: 9916713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity.
    Stebbins CC; Watzl C; Billadeau DD; Leibson PJ; Burshtyn DN; Long EO
    Mol Cell Biol; 2003 Sep; 23(17):6291-9. PubMed ID: 12917349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells.
    Sarkar S; Germeraad WT; Rouschop KM; Steeghs EM; van Gelder M; Bos GM; Wieten L
    PLoS One; 2013; 8(5):e64835. PubMed ID: 23724099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shp-2 is critical for ERK and metabolic engagement downstream of IL-15 receptor in NK cells.
    Niogret C; Miah SMS; Rota G; Fonta NP; Wang H; Held W; Birchmeier W; Sexl V; Yang W; Vivier E; Ho PC; Brossay L; Guarda G
    Nat Commun; 2019 Mar; 10(1):1444. PubMed ID: 30926899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.